Drug design
By: Kulkarni, M. V.
Contributor(s): Bothara, K. G.
Publisher: Pune Nirali Prakashan 2009Edition: 4th.Description: 270, 24*18.1 Pages | Binding - Paperback |.ISBN: 818579011-6.Subject(s): PHARMACEUTICAL CHEMISTRYDDC classification: 615.19 Online resources: Click here to access online Summary: Drug design, Enzyme Inhibitors, Anti AID's Agents, Microbial bioconversions in steriods, Microbial bioconversions in prostaglandins, Neurotransmitters, drugs acting on cardiovascular system, Quantitative structure, activity relationship.pharmaceutical industrial operations, Statutory & Regulatory Aspects.Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|---|
Text Books | School of Pharmacy Reference Section | Reference | 615.19 KUL/BOT (Browse shelf) | Not For Loan | B1219 | ||
Text Books | School of Pharmacy General Stacks | Circulation | 615.19 KUL/BOT (Browse shelf) | Available | B1220 | ||
Text Books | School of Pharmacy General Stacks | Circulation | 615.19 KUL/BOT (Browse shelf) | Available | B1221 | ||
Text Books | School of Pharmacy General Stacks | Circulation | 615.19 KUL/BOT (Browse shelf) | Available | B1222 | ||
Text Books | School of Pharmacy General Stacks | Circulation | 615.19 KUL/BOT (Browse shelf) | Available | B1223 |
Total holds: 0
Browsing School of Pharmacy Shelves , Shelving location: General Stacks , Collection code: Circulation Close shelf browser
No cover image available | ||||||||
615.19 KAR Medicinal chemistry | 615.19 KHO Solvent extraction sepration of element with liquid Ion exchanges | 615.19 KOR Essentials of medicinal chemistry | 615.19 KUL/BOT Drug design | 615.19 KUL/BOT Drug design | 615.19 KUL/BOT Drug design | 615.19 KUL/BOT Drug design |
Drug design, Enzyme Inhibitors, Anti AID's Agents, Microbial bioconversions in steriods, Microbial bioconversions in prostaglandins, Neurotransmitters, drugs acting on cardiovascular system, Quantitative structure, activity relationship.pharmaceutical industrial operations, Statutory & Regulatory Aspects.
There are no comments for this item.